Pressure-Based Volume Measurement Technology for In-process Measurement of Microplate Contents
Poster Feb 10, 2015
John Thomas Bradshaw, Bill Gigante, Christoph Schwedes
Modern drug discovery and research labs are utilizing complex automation systems to assist in high throughput screening of novel drug candidates. A large portion of these laboratories are using ANSI-SBS-standard 96- and 384-well plates to achieve the necessary throughput. The vol¬ume of sample transferred into and out of these plates can be critical to the success of assays or validation of procedures. One specific example is in the preparation of mother/daughter plates from compounds pulled from library stores. It is not uncommon to find a compound storage tube containing less volume than expected, which in turn may result in incorrect volumes delivered to mother plates to be used for screening tests. A simple approach to determining volumes in these prepared mother plates is needed.
Using a new pressure-based volume measurement technology, it is now possible to make direct measurements of volumes in microplates. This new measurement technology is found in the Artel SDS, which provides precise and accurate volume measurements in 96- and 384-well micro¬plates. The SDS technology determines well volume by sealing and pressurizing individual wells and is able to accurately and repeatedly measure the contents of a well without regard to the shape of the well, type of plastic, color of material, or type of sample.
Using four common plate types and a variety of precision metal cylinders of known volume, the basic operational principles of this volume measurement technology is demonstrated herein.
Regulatory T-Cells (Tregs) Within Bone Marrow-Derived Stem Cells (BMSCs) Actively Confer Immunomodulatory and Neuroprotective Effects Against StrokePoster
We found a distinct subpopulation of Tregs within BMSCs. Tregs and BMSCs in co-culture conferred neuroprotection that varied in a dose-dependent manner. Tregs minimized stem cell production of IL-6, a pro-inflammatory cytokine, and inhibited BMSC secretion of FGF-beta, a cytokine related to BMSC proliferation and differentiation. The ratio of Tregs found natively in BMSCs is optimally adapted to provide the maximum neuroprotective benefit of stem cell treatment after ischemic stroke.READ MORE
Internet-Based Biomarker Collection Feasibility: Experiences of a Tobacco Cessation Program for People Living with HIVPoster
This project introduces video-conferencing as a method for biomarker collection in research and will explain how biomarker collection via video-conferencing was implemented in a pilot ehealth intervention.READ MORE
Alterations in Immunophenotype of Autoimmune-prone Hypomorphic RAG-deficient Patients with CID-G/AI PhenotypePoster
Patients with partial deficiency of recombination-activating genes 1 or 2 (RAG1/2) can present with a wide spectrum of primary immunodeficiencies including combined immunodeficiency with granuloma and/or autoimmunity (CID-G/AI). Prior case reports have highlighted alterations in B and T cell compartments; however comprehensive characterization of these cell populations with focus on autoreactive-prone subsets has not been reported.READ MORE
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018